bluebird bio (BLUE) PT Lowered to $160 at JPMorgan, Following Announcement Of COVID-19 Impact Assessment
Tweet Send to a Friend
JPMorgan analyst Cory Kasimov lowered ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
